ADVB (Advanced Biomed Corp) Earnings per share growth rate in current year
The viability of Advanced Biomed Inc (ADVB) relies on the adoption rates of early diagnostics and the pursuit of investment. The volatility of annual earnings per share illustrates the impact of these factors, where 0.00 captures the current value of the indicator. Cost optimization is based on the robotization of tumor screening and strict adherence to cleanroom assembly standards during the disposal of chemical reagents.
Financial and market metric breakdowns for advanbiomed.com (ADVB)
- stock price and consensus target price:
- business market valuation indicators:
- balance sheet equity data:
- debt burden and liquidity indicators:
- earnings and market multiples details:
ADVB - Net Profit|Net Profit Forecast Advanced Biomed Inc|ADVB - Price to Earnings Ratio|Future Price to Earnings Multiple Advanced Biomed|ADVB - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ADVB|ADVB - Operating profit EBITDA|Net earnings per share for the last four quarters Advanced Biomed|ADVB - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months advanbiomed.com|ADVB - Earnings per share growth in current year|Expected earnings per share growth for next year Advanced Biomed Inc
Basic company analysis:Advanced Biomed Corp
For Advanced Biomed Inc (ADVB), earnings per share dynamics serve as an indicator of the effectiveness of monetizing scientific research. This metric calculates the percentage deviation of the current EPS from the value of the same period last year. By analyzing the annual EPS growth trajectory, an investor assesses the pace of business scaling. Growth in this indicator confirms the commercial demand for diagnostic oncology systems. A steady increase in profit verifies the transformation of high scientific potential into real financial results.
Direct competitors
BeiGene Ltd. - Earnings per share increase in current year|HALO (Halozyme Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Revolution Medicines Corp RVMD|Earnings growth in current year AAPG|Earnings growth in current year cgoncology.com (CGON)|Earnings growth in current year URGN (UroGen Pharma)|BCAX: Earnings per share growth this year|PSNL: Net earnings per share growth this year|ERAS: Earnings per share growth in current year|DCTH: Earnings growth in current year|ymabs.com (YMAB) - Earnings growth in current year|Earnings per share growth in current year Aura Biosciences|Earnings per share growth this year CADL (Candel)|Earnings growth in current year ARAY|Net earnings per share growth this year sellaslifesciences.com SLS|Earnings growth in current year ACTU (Actuate Therapeutics, Inc.)|citiusonc.com (CTOR) - Earnings per share growth rate in current year|TuHURA - Earnings growth in current year|TARA (Protara Therapeutics Inc) - Earnings per share growth this year|FATE (Fate Therapeutics Corp) - Net earnings per share growth this year|Aadi Bioscience - Earnings per share increase in current year|TCRX (TScan Therapeutics Inc) - Earnings growth in current year|Earnings per share growth in current year CSBR|Earnings growth in current year XBIT|Expected net earnings per share growth this year cel-sci.com|Earnings per share growth in current year OS Therapies Inc OSTX|radiopharmtheranostics.com (RADX) - Earnings per share growth rate in current year|ARTV - Earnings per share growth in current year|Adlai Nortye Ltd. (ANL) - Net earnings per share growth this year|VERU: Earnings growth in current year|Earnings per share growth rate in current year Tempest Therapeutics Inc (TPST)|XLO (Xilio Therapeutics Inc) - Earnings growth in current year|Earnings per share growth this year RENB (Enochian BioSciences)|Net earnings per share growth this year MURA (Mural Oncology plc)|KAPA (kairospharma.com) - Earnings per share increase in current year|Earnings growth in current year OKUR (OnKure Therapeutics)|Expected net earnings per share growth this year CytoMed Therapeutics Ltd (GDTC)|CRIS - Earnings per share growth in current year|APLM (Apollomics, Inc.) - Earnings per share growth this year|THAR: Earnings growth in current year|Net earnings per share growth this year genprex.com|CLDI (Calidi Biotherapeutics Inc.) - Earnings growth in current year|Earnings growth in current year sunshinebiopharma.com|Earnings growth in current year XBIO|Salarius Pharma - Earnings per share growth this year|Purple Biotech - Net earnings per share growth this year|American Oncology Network Inc - Earnings per share growth in current year|BeiGene - Earnings growth in current year|CKPT: Earnings per share growth in current year|ELEV: Earnings growth in current year|Net earnings per share growth this year iCAD|IKNA (Ikena Oncology Inc.) - Earnings growth in current year|Earnings growth in current year notablelabs.com|Earnings per share growth in current year Viracta Therapeutics (VIRX)|MorphoSys Inc - Earnings per share growth this year|Earnings growth in current year NAYA (NAYA Bio)|AAPGV - Net earnings per share growth this year
